Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Tactile Medical to Participate in Two Upcoming Investor Conferences in November and December
-
GenMark Diagnostics to Participate in Upcoming Investor Conferences
-
TELA Bio Announces Closing of Initial Public Offering of Common Stock
-
GenMark Diagnostics to Participate in Upcoming Investor Conferences
-
TELA Bio Announces Closing of Initial Public Offering of Common Stock
-
Palatin Technologies (PTN) PT Lowered to $4 at Canaccord Genuity
-
Canaccord Genuity Downgrades Yellow Pages Ltd. (Y:CN) (YLWDF) to Hold
-
Forty Seven Inc. (FTSV) PT Lowered to $22 at Canaccord Genuity
-
Gryphon Networks Announces Strategic Investment From Sverica Capital Management
-
Net Asset Value(s)
-
New Water Capital Announces Recapitalization of Two Tier III Electronics Manufacturing Services (EMS) Providers
-
Stradigi AI Raises $53 Million CAD Series A Funding to Fuel North American Expansion
-
ATEC to Participate in The Canaccord Genuity MedTech and Diagnostics Forum and The Piper Jaffray 31st Annual Healthcare Conference
-
InMode to Present at Canaccord Genuity MedTech & Diagnostics Forum
-
Form 8.3 - Accesso Technology Group plc
-
Aspen Group (ASPU) PT Raised to $9 at Canaccord Genuity
-
Form 8.3 - Accesso Technology Group plc
-
Lions Gate Entertainment Corp. (LGF-b) PT Lowered to $15 at Canaccord Genuity
-
TELA Bio (TELA) IPO Opens Higher
-
Transaction in Own Shares
-
Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
-
TELA Bio, Inc. (TELA) Prices 4M Share IPO at $13/Sh
-
Closed Period Notification
-
Form 8.3 - Accesso Technology Group plc
-
TELA Bio Announces Pricing of Initial Public Offering of Common Stock
-
TELA Bio Announces Pricing of Initial Public Offering of Common Stock
-
Digi Int'l (DGII) to Acquire Opengear
-
KORU Medical Systems to Present at November Investor Conferences
-
Digi International To Acquire Opengear
-
Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019
-
Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019
-
Asanko Gold Reports Q3 2019 Results
-
Caris Life Sciences to Present at Two Investor Healthcare Conferences
-
Form 8.3 - Accesso Technology Group Plc
-
Canaccord Genuity Group Inc. Reports Second Quarter Fiscal 2020 Results
-
Merit Medical to Participate at Three Upcoming Conferences
-
TransMedics Group (TMDX) PT Lowered to $25 at Canaccord Genuity
-
DermTech to Present at Upcoming Investor Conferences
-
Canaccord Genuity Downgrades MeetMe (MEET) to Hold
-
Form 8.3 - Accesso Technology Group plc
-
Canaccord Genuity Starts Global Blood Therapeutics (GBT) at Hold
-
Regeneron Pharma (REGN) PT Raised to $340 at Canaccord Genuity
-
Seres Therapeutics (MCRB) PT Lowered to $11 at Canaccord Genuity
-
Codexis to Participate in Four Investment Conferences in November
-
Form 8.3 - Accesso Technology Group plc
-
Net Asset Value(s)
-
Misonix to Participate in Three Upcoming Investor Conferences
-
Directorate change
-
Radisson appoints Rahul Paul as CFO

